COVID-19: Keep up to date with the latest pharmaceutical and healthcare news as the pandemic evolves

Pharma’s coming home

Growing confidence in the life sciences industry and the currency of individual experience has given patient centricity an injection of new life. It has also been essential in suppressing the coronavirus and establishing humanity’s position in the race against time
Rising to the challenge

Jenny Ousbey outlines what we’ve learnt from the Patient Partnership Index 2021
Golden opportunities

Collaborative working is a cornerstone of the government’s White Paper for the NHS, but how can pharmaceutical companies best get in on the act? Wilmington Healthcare’s Oli Hudson looks at six distinct ways in which industry can partner with NHS organisations to mutual advantage

News

View all

NICE publishes ‘rapid’ guideline on rare blood clots associated with COVID-19 jab

Although condition is extremely rare, it requires ‘swift diagnosis and urgent treatment’ says NICE

30th July 2021

GSK’s Nucala approved to treat chronic rhinosinusitis with nasal polyps

Nucala is the first IL-5 inhibitor to be approved for adult CRSwNP patients in the US

30th July 2021

UK genomics market valued at over £5bn, according to new report

‘Genomics Nation’ report launched in a bid to showcase the thriving UK genomics sector

30th July 2021

GPs call for rescue plan to ‘save’ general practice in the UK

RCGP's chair said that general practice in the UK is currently at a 'breaking point'

30th July 2021

Ipsen to collaborate with BAKX Therapeutics on early-stage oncology asset

BKX-001 is designed to target the apoptosis, or programmed cell death, pathway

29th July 2021

Web Exclusives

View all

Impact of immunosuppressants on COVID-19 vaccine response

Dr Daniel Streetman considers whether immunosuppressants can reduce the response to COVID-19 vaccines

Deeper digitisation

Three ways technology can support NHS workers today, tomorrow and into the future

Green shoots, grey hairs and TLC

How start-ups can bridge the gap and grow with venture capital support

Weathering the COVID storm

Four ways pharma must embrace tech to weather the COVID storm

Magazine

View more from the latest edition

Diversity through development

How tech is enabling a more representative future for pharma

MAGAZINE EXCLUSIVE

Supporting the new healthcare normal

The healthcare industry has successfully brought effective vaccines to market despite massive disruption from COVID-19. But with global supply chains still stretched, what are the priorities for supply chain players as we move towards a ‘new normal’?

MAGAZINE EXCLUSIVE

A little less conversation, a little more action

Sustainability commitments alone won’t stop the climate crisis

Six lessons for medical congresses

Medical congresses can learn important lessons from how consumer brands have adapted to a COVID world

Smart People: Juliet Bauer

PharmaTimes talks to Juliet Bauer about her role as MD of Livi UK and the digital healthcare landscape

The patent waiver debate

In recent months an intense debate has arisen about a potential waiving of patent rights on COVID vaccines. This article looks at the background to this debate, the relevance of patent rights to the COVID vaccines and the various issues raised by the different protagonists.

Global trends in clinical research

Pharma R&D activity surges even without COVID-19

Engaging the masses

How the healthcare sector can learn from the ad industry to better engage target audiences and improve education

Thought Leadership

View all

A life in a day

How immersive learning experiences can support and elevate patient-centricity goals in the pharma industry

A ‘triple win’ for pharma

Patient centricity that delivers the ‘triple win’ is a business essential for pharma

Optimising NHS patient pathways in renal care

Sue Thomas explains how Wilmington Healthcare's unique behavioural methodology is helping to define best practice pathways for patients with chronic kidney disease (CKD) during the pandemic

Defining optimal patient pathways in a fast-changing NHS

Steve How explains how Wilmington Healthcare's unique behavioural methodology is being used to map patient journeys across the integrated care landscape

Webinars

View all

Designing Pharma organisations for success

Wednesday, 28 September 2016 - 11:00 am

Across all industries, people are changing the ways they engage with products, services, and brands.

George Underwood

FREE - Listen again now - | VIEW NOW

Focusing on Patient-centricity for the Future of Pharma

Wednesday, 21 July 2021 - 2:00 pm

In healthcare, the patient voice is arguably the most important. Services and care work best when a person’s needs are fully met and they feel heard, respected and valued.

Mark Doyle, co-founder of The Method and creator of A Life in a Day

FREE | ATTEND